*/ *|MC_PREVIEW_TEXT|* We Have The Scientists . . . A Special Introduction from Dr. Saud A. Sadiq Dr. Saud A. Sadiq, Director and Chief Research Scientist of Tisch MS Research Center of New York invites you to learn more about our cutting-edge investigations into the cause and cure of MS. He will...
In our Phase I two-year follow up study, our clinical team monitored the Phase I patients for two additional years after their treatment. Our results showed that there were no long-term side effects from the MSC-NP therapy. Importantly, a subset of patients showed sustained clinical improvement two...
Merry Christmas from all of us at the Tisch MSRCNY! Our office will be closed for the holiday beginning on Wednesday, December 23rd at 3:00pm and will reopen on Monday, December 28th at 9:00 AM. A neurologist is on-call and may be reached at (212) 265-8070 for any MS-related emergencies. Wishing a...
Tisch MSRCNY will be closed for the holiday beginning on Thursday, December 31st, and will reopen on Monday, January 4th at 9:00 AM. We wish you and your family a happy and healthy New Year!
January 4, 2019: Our experts sat down to discuss a paper on disease-specific oligodendrocyte lineage cells and their relationship with MS. Disease-specific Oligodendrocyte Lineage Cells Arise in Multiple Sclerosis Researchers have found that a subset of oligodendrocytes, the cells that produce...
January 11, 2019: At Journal Club, our experts sat down to discuss a paper on Epstein Barr Virus (EBV) specific T cell therapy for patients with progressive MS. Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis Researchers were able to use patient blood samples to...
Tisch MSRCNY will be closed on Monday, January 21st, in observance of Martin Luther King Jr. Day. "Faith is taking the first step even when you don't see the whole staircase." -Martin Luther King Jr.
January 18, 2019: At Journal Club, our experts sat down to discuss a paper on exosomes derived from mesenchymal stem cells. Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia...
January 25, 2019: At Journal Club, our experts sat down to discuss a paper on serum GFAP levels as a potential disease biomarker. Abdelhak et al 2018 - Serum GFAP as a biomarker for disease severity in multiple sclerosis GFAP is a protein expressed in astrocytes that helps support their functions...